Central nervous system cytokine gene expression: Modulation by lead

Journal of Biochemical and Molecular Toxicology

Volumn 25, Issue 1, 2011, Pages 41-54

  Kasten Jolly, Jane ^a   Heo, Yong ^b   Lawrence, David A ^a  

^a WADSWORTH CENTER   (United States)

^b Catholic University of Daegu   (South Korea)

Author keywords

Astrocyte; Brain; Central Nervous System; Cytokine; Lead; Neuron; Signal Transduction; Transcription

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; GLIAL FIBRILLARY ACIDIC PROTEIN; HEAVY METAL; INTERLEUKIN 6; LEAD; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HEAVY METAL POISONING; HOUSEKEEPING GENE; MALE; MICROARRAY ANALYSIS; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; ASTROCYTES; BRAIN; CENTRAL NERVOUS SYSTEM; CYTOKINES; FEMALE; GENE EXPRESSION; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN-1; INTERLEUKIN-18; INTERLEUKIN-6; LEAD; LEARNING; MALE; MEMORY, LONG-TERM; MICE; MICE, INBRED BALB C; MICROARRAY ANALYSIS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1;

MUS;

EID: 79951504901     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.20358     Document Type: Article

References (96)

1. Needleman H. Lead poisoning. Annu Rev Med 2004;55:209-222.
2. Lanphear BP, Hornung R, Khoury J, Yolton K, Baghurst P, Bellinger DC, et al. Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect 2005;113(7):894-899.
3. Goldstein GW. Developmental neurobiology of lead toxicity. In: Needleman HL, editor. Human lead exposure. Boca Raton, FL: CRC Press; 1992. pp 137-154.
4. Bradbury MWB, Deane R. Permeability of the blood-brain barrier to lead. Neurotoxicology 1993;14(2-3):131-136.
5. Snyder JE, Filipov NM, Parsons PJ, Lawrence DA. The efficiency of maternal transfer of lead and its influence on plasma IgE and splenic cellularity of mice. Toxicol Sci 2000;57(1):87-94.
6. Krigman MR. Neuropathology of heavy metal intoxication. Environ Health Perspect 1978;26:117-120.
7. Toews AD, Krigman MR, Thomas DJ, Morell P. Effect of inorganic lead exposure on myelination in the rat. Neurochem Res 1980;5(6):605-616.
8. Bressler JP, Goldstein GW. Mechanisms of lead neurotoxicity. Biochem Pharmacol 1991;41(4):479-484.
9. Kern M, Audesirk G. Inorganic lead may inhibit neurite development in cultured rat hippocampal neurons through hyperphosphorylation. Toxicol Appl Pharmacol 1995;134(1):111-123.
10. Qian Y, Tiffany-Castiglioni E. Lead-induced endoplasmic reticulum (ER) stress responses in the nervous system. Neurochem Res 2003;28(1):153-162.
11. Dyatlov VA, Lawrence DA. Neonatal lead exposure potentiates sickness behavior induced by Listeria monocytogenes infection of mice. Brain Behav Immun 2002;16(4):477-492.
12. Lawrence DA. Immuntoxicity of heavy metals. In: Dean JH, Luster MJ, Munson R, editors. Immunotoxicology and Immunopharmacology. New York: Raven Press; 1985. pp 341-350.
13. Banks WA. Blood-brain barrier transport of cytokines: a mechanism for neuropathology. Curr Pharm Des 2005;11:973-984.
14. Dunn AJ, Wang J. Cytokine effects on CNS biogenic amines. Neuroimmunomodulation 1995;2:319-328.
15. Harbuz MS, Stephanou A, Sarlis N, Lightman SL. The effects of recombinant human interleukin (IL)-1 alpha, IL-1 beta or IL-6 on hypothalamo-pituitary-adrenal axis activation. J Endocrinol 1992;133(3):349-355.
16. Stouthard JM, Romijn JA, van der Poll T, Endert E, Klein S, Bakker PJ, et al. Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol 1995;268, E813-E819.
17. Hopkins SJ, Rothwell NJ. Cytokines and the nervous system I: expression and recognition. Trends Neurosci 1995;18(2):83-88.
18. Luheshi G, Rothwell N. Cytokines and fever. Int Arch Allergy Immunol 1996;109:301-307.
19. Kishikawa H, Lawrence DA. Differential production of interleukin-6 in the brain and spleen of mice treated with lipopolysaccharide in the presence and absence of lead. J Toxicol Environ Health A 1998;53:357-373.
20. Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nat Rev Neurosci 2001;2(10):734-744.
21. Ransohoff RM, Benveniste EN, editors. Cytokines and the CNS. New York: Taylor & Francis Group; 2006.
22. Strle K, Zhou J-H, Shen W-H, Broussard SR, Johnson RW, Freund GG, et al. Interleukin-10 in the brain. Crit Rev Immunol 2001;21:427-449.
23. Szelenyi J. Cytokines and the central nervous system. Brain Res Bull 2001;54(4):329-338.
24. Gadient RA, Otten U. Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development. Brain Res 1994;637(1):10-14.
25. Gruol DL, Nelson TE. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol 1997;15:307-339.
26. Du X, Everett ET, Wang G, Lee W-H, Yang Z, Williams D. Murine interleukin-11 (IL-11) is expressed at high levels in the hippocampus and expression is developmentally regulated in the testis. J Cell Physiol 1996;168(2):362-372.
27. Maslinska D. The cytokine network and interleukin-15 (IL-15) in brain development. Folia Neuropathol 2001;39:43-47.
28. Hanisch U-K, Lyons SA, Prinz M, Nolte C, Weber JR, Kettenmann H, et al. Mouse brain microglia express interleukin-15 and its multimeric receptor complex functionally coupled to Janus Kinase activity. J Biol Chem 1997;272(46):28853-28860.
29. Kurowska M, Rudnicka W, Maslinska D, Maslinska W. Expression of IL-15 and IL-15 receptor isoforms in select structures of human fetal brain. Ann NY Acad Sci 2002;966:441-445.
30. Andre R, Wheeler RD, Collins PD, Luheshi GN, Pickering-Brown S, Kimber I, et al. Identification of a truncated IL-18Rβ mRNA: a putative regulator of IL-18 expressed in rat brain. J Neuroimmunol 2003;145(1):40-45.
31. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 regulates both TH1 and TH2 responses. Annu Rev Immunol 2001;19:423-474.
32. Wheeler RD, Culhane AC, Hall MD, Pickering-Brown S, Rothwell NJ, Luheshi GN. Detection of the interleukin 18 family in rat brain by RT-PCR. Mol Brain Res 2000;77(2):290-293.
33. Wheeler RD, Brough D, Le Feuvre RA, Takeda K, Iwakura Y, Luheshi GN, et al. Interleukin-18 induces expression and release of cytokines from murine glial cells: interactions with interleukin-1β. J Neurochem 2003;85(6):1412-1420.
34. Culhane AC, Hall MD, Rothwell NJ, Luheshi GN. Cloning of rat brain interleukin-18 cDNA. Mol Psychiatry 1998;3:362-366.
35. Cannella B, Raine CS. Multiple sclerosis: cytokine receptors on oligodendrocytes predict innate regulation. Ann Neurol 2004;55(1):46-57.
36. Conti B, Park LC, Calingasan NY, Kim Y, Kim H, Bae Y, et al. Cultures of astrocytes and microglia express interleukin 18. Brain Res Mol Brain Res 1999;67(1):46-52.
37. Kurschner C, Yuzaki M. Neuronal interleukin-16 (NIL-16): a dual function PDZ domain protein. J Neurosci 1999;19(18):7770-7780.
38. Constam DB, Philipp J, Malipiero UV, ten Dijke P, Schachner M, Fontana A. Differential expression of transforming growth factor-β1, β2, and β3 by glioblastoma cells, astrocytes, and microglia. J Immunol 1992;148(5):1404-1410.
39. Gomes FCA, Sousa VdeO, Romao L. Emerging roles for TGF-β1 in nervous system development. Int J Dev Neurosci 2005;23(5):413-424.
40. Darnall BD, Suarez EC. Sex and gender in psychoneuroimmunology research: past, present, and future. Brain Behav Immun 2009;23(5):595-604.
41. Kim WG, Mohney RP, Wilson B, Jeohn GH, Liu B, Hong JS. Regional difference in susceptibility to LPS-induced neurotoxicity in the rat brain: role of microglia. J Neurosci 2000;20(16):6309-6316.
42. Lawson LJ, Perry VH, Dri P, Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 1990;39(1):151-170.
43. Aloisi F, Care A, Borsellino G, Gallo P, Rosa S, Bassani A, et al. Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factor) by normal human astrocytes in response to IL-1β and tumer necrosis factor-α. J Immunol 1992;149(7):2358-2366.
44. Cannella B, Sizing ID, Benjamin CD, Browning JL, Raine CS. Antibodies to lymphotoxin α (LTα) and LTβ recognize different glial cell types in the central nervous system. J Neuroimmunol 1997;78(2):172-179.
45. Heo Y, Lee WT, Lawrence DA. Differential effects of lead and cAMP on development and activities of Th1- and Th2-lymphocytes. Toxicol Sci 1998;43(1):172-185.
46. Wanf J, Shannon MF, Young IG. A role for Ets1, synergizing with AP-1 and GATA-3 in the regulation of IL-5 transcription in mouse Th2 lymphocytes. Int Immunol 2006;18(2):313-323.
47. Dai J, Huang C, Wu J, Yang C, Frenkel K, Huang X. Iron-induced interleukin-6 gene expression: possible mediation through the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways. Toxicology 2004;203(3):199-209.
48. Liu G, Ding W, Liu X, Mulder K. c-Fos is required for TGFβ1 production and the associated paracrine migratory effects of human colon carcinoma cells. Mol Carcinog 2006;45(8):582-593.
49. Persson E, Voznesensky OS, Huang Y-F, Lerner UH. Increased expression of interleukin-6 by vasoactive intestinal peptide is associated with regulation of CREB, AP-1 and C/EBP, but not NF-κB, in mouse calvarial osteoblasts. Bone 2005;37(4):513-529.
50. Xie J, Pan H, Yoo S, Gao S-J. Kaposi's sarcoma-associated herpesvirus induction of AP-1 and interleukin-6 during primary infection mediated by multiple mitogen-activated protein kinase pathways. J Virol 2005;79(24):15027-15037.
51. Abecassis L, Rogier E, Vazquez A, Atfi A, Bourgeade M-F. Evidence for a role of MSK1 in transforming growth factor-β-mediated responses through p38α and Smad signaling pathways. J Biol Chem 2004;279(29):30474-30479.
52. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-β family signaling. Nature 2003;425(6958):577-584.
53. ten Dijke, P, Hill CS. New insights into TGF-β - Smad signaling. Trends Biochem Sci 2004;29(5):265-273.
54. Zhang Y, Feng X-H, Derynck R. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription. Nature 1998;394(6696):909-913.
55. Taga T, Fukuda S. Role of IL-6 in the neural stem cell differentiation. Clin Rev Allergy Immunol 2005;28:249-256.
56. de Sampaio e Spohr TCL, Martinex R, da Silva EF, Neto VM, Gomes FCA. Neuro-glia interaction effects on GFAP gene: a novel role for transforming growth factor-β1. Eur J Neurosci 2002;16(11):2059-2069.
57. Sousa VdeO, Romao L, Neto VM, Gomes FCA. Glial fibrillary acidic protein gene promoter is differently modulated by transforming growth factor beta-1 in astrocytes from distinct brain regions. Eur J Neurosci 2004;19(7):1721-1730.
58. Ojala J, Alafuzoff I, Herukka S-K, van Groen T, Tanila H, Pirttila T. Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients. Neurobiol Aging 2009;30(2):198-209.
59. Curran B, O'Conner JJ. The pro-inflammatory cytokine interleukin-18 impairs long-term-potentiation and NMDA receptor mediated transmission in the rat hippocampus in vitro. Neuroscience 2001;108(1):83-90.
60. MAPK phosphorylation in the hippocampus of immature rats. Br Res 2004;998(1):65-72.
61. MAPK by lead in the cerebellum of Brazilian catfish Rhamdia quelen. Aq Toxicol 2006;77(1):98-104.
62. Thomas GM, Huganir RL. MAPK cascade signaling and synaptic plasticity. Nature Rev. Neuroscience 2004;5:173-183.
63. Schwab JM, Nguyen TD, Meyermann R, Schluesener HJ. Human focal cerebral infarctions induce differential lesional interleukin-16 (IL-16) expression confined to infiltrating granulocytes, CD8+ T-lymphocytes and activated microglia/macrophages. J Neuroimmunol 2001;114(2):232-241.
64. Zhao M-L, Si Q, Lee SC. IL-16 expression in lymphocytes and microglia in HIV-1 encephalitis. Neuropathol Appl Neurobiol 2003;30(3):233-242.
65. Chen H-H, Ma T, Ho IK. Protein kinase C in rat brain is altered by developmental lead exposure. Neurochem Res 1999;24(3):415-421.
66. Costa LG, Guizzetti M, Lu H, Bordi F, Vitalone A, Tita B, et al. Intracellular signal transduction pathways as targets for neurotoxicants. Toxicology 2001;160(1):19-26.
67. Cremin JD Jr., Smith DR. In vitro and in vivo Pb effects on brain protein kinase C activity. Environ Res 2002;90(3):191-199.
68. Long GJ, Rosen JF, Schanne FAX. Lead activation of protein kinase C from rat brain. J Biol Chem 1994;269(2):834-837.
69. Bressler J, Kim K, Chakraborti T, Goldstein G. Molecular mechanisms of lead neurotoxicity. Neurochem Res 1999;24(4):595-600.
70. Kim K-A, Chakraborti T, Goldstein GW, Bressler JP. Immediate early gene expression in P12 cells exposed to lead: requirement for protein kinase C. J Neurochem 2000;74(3):1140-1146.
71. Ramesh GT, Manna SK, Aggarwal BB, Jadhav AL. Lead exposure activates nuclear factor kappa B, activator protein-1, c-jun N-terminal kinase and caspases in the rat brain. Toxicol Lett 2001;123(3):195-207.
72. RSK signaling pathway in human astrocytoma cells via a protein kinase C-dependent mechanism. J Pharmacol Exp Ther 2002;300(3):818-823.
73. Atkins DS, Basha MR, Zawia NH. Intracellular signaling pathways involved in mediating the effects of lead on the transcription factor Sp1. Int J Dev Neurosci 2003;21(5):235-244.
74. Crumpton T, Atkins DS, Zawia NH, Barone S. Lead exposure in pheochromocytoma (PC12) cells alters neural differentiation and Sp1 DNA-binding. Neurotoxicology 2001;22(1):49-62.
75. Bamba S, Andoh A, Yasui H, Makino J, Kim S, Fujiyama Y. Regulation of IL-11 expression in intestinal myofibroblasts: role of c-Jun, AP-1-and MAPK-dependent pathways. Am J Physiol Gastrointest Liver Physiol 2003;285(3):529-538.
76. NCBI (National Center for Biotechnology Information). 2006. Nucleotide. Available at, accessed September 1, 2006.
77. Yang L, Yang Y-C. Regulation of interleukin (IL)-11 gene expression in IL-1 induced primate bone marrow stromal cells. J Biol Chem 1994;269(52):32732-32739.
78. Kang S-H, Brown DA, Kitajima I, Xu X, Heidenreich O, Gryaznov S, et al. Binding and functional effects of transcriptional factor Sp1 on the murine interleukin-6 promotor. J Biol Chem 1996;271(13):7330-7335.
79. Kim Y, Ratziu V, Choi S-G, Lalazar A, Theiss G, Dang Q, et al. Transcriptional activation of transforming growth factor β1 and its receptors by the Kruppel-like Zf9/core promoter-binding protein and Sp1. J Biol Chem 1998;273(50):33750-33758.
80. Sanceau J, Kaisho T, Hirano T, Wietzerbin J. Triggering of the human interleukin-6 gene by interferon-γ and tumor necrosis factor-α in monocytic cells involves cooperation between interferon regulatory factor-1, NFκB, and Sp1. J Biol Chem 1995;270(46):27920-27931.
81. Klasen HJ, Imfeld KL, Kirov II, Tai L, Gage FH, Young MJ, et al. Expression of cytokines by multipotent neural progenitor cells. Cytokine 2003;22(4):101-106.
82. Van Wagoner NJ, Benveniste EN. Interleukin-6 expression and regulation in astrocytes. J Neuroimmunol 1999;100(1):124-139.
83. Wyss-Coray T, Borrow P, Brooker MJ, Mucke L. Astroglial overproduction of TGF-β1 enhances inflammatory central nervous system disease in transgenic mice. J Neuroimmunol 1997;77(1):45-50.
84. Flanders KC, Ren RF, Lippa CF. Transforming growth factor-βs in neurodegenerative disease. Prog Neurobiol 1998;54(1):71-85.
85. Wahl SM, Allen JB, McCartney-Francis N, Marganti-Kossmann MC, Kossmann T, Ellingsworth L, et al. Macrophage- and astrocyte-derived transforming growth factor β as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J Exp Med 1991;173(4):981-991.
86. Buisson A, Lesne S, Docagne F, Ali C, Nicole O, MacKenzie ET, et al. Transforming growth factor-β and ischemic brain injury. Cell Mol Neurobiol 2003;23(4):539-549.
87. Cafferty WBJ, Gardiner NJ, Das P, Qiu J, McMahon SB, Thompson SWN. Conditioning injury-induced spinal axon regeneration fails in interleukin-6 knockout mice. J Neurosci 2004;24(18):4432-4443.
88. Bravo J, Heath JK. Receptor recognition by gp130 cytokines. EMBO J 2000;19(11):2399-2411.
89. Teng FYH, Tang BL. Axonal regeneration in adult CNS neurons-signaling molecules and pathways. J Neurochem 2006;96(6):1501-1508.
90. Sometani A, Kataoka H, Nitta A, Fukumitsu H, Nomoto H, Furukawa S. Transforming growth factor-b1 enhances expression of brain-derived neurotrophic factor and its receptor, TrkB, in neurons cultured from rat cerebral cortex. J Neurosci Res 2001;66(3):369-376.
91. Harry GJ, Schmitt TJ, Gong Z. Brown H, Zawia N, Evans HL. Lead-induced alterations of glial fibrillary acidic protein (GFAP) in the developing rat brain. Toxicol Appl Pharmacol 1996;139(1):84-93.
92. Zawia NH, Harry GJ. Developmental exposure to lead interferes with glial and neuronal differential gene expression in the rat cerebellum. Toxicol Appl Pharmacol 1996;138(1):43-47.
93. Zhu G, Mehler MF, Mabie PC, Kessler JA. Developmental changes in progenitor cell responsiveness to cytokines. J Neurosci Res 1999;56(2):131-145.
94. Deng W, Poretz RD. Protein kinase C activation is required for the lead-induced inhibition of proliferation and differentiation of cultured oligodendroglial progenitor cells. Brain Res 2002;929(1):87-95.
95. Morgan RE, Garavan H, Smith EG, Driscoll LL, Levitsky DA, Strupp BJ. Early lead exposure produces lasting changes in sustained attention, response initiation, and reactivity to errors. Neurotoxicol Teratol 2001;23(6):519-531.
96. +2) impairs long-term memory and blocks learning-induced increases in hippocampal protein kinase C activity. Toxicol Appl Pharmacol 2004;200(1):27-39.